{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:57:26Z","timestamp":1781632646653,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cognitive impairment is a recognised feature of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). Despite advances in understanding cognitive impairment in ALS, no fluid biomarkers reliably predict these changes. Prior research in Alzheimer disease (AD) has demonstrated that CSF protein ratios enhance biomarker accuracy by mitigating inter-individual variability, improving diagnostic precision. In AD, ratios involving synaptic markers have shown stronger associations with cognitive outcomes than single proteins, motivating evaluation of a similar ratio-based approach in ALS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Building on findings from the AD field, we analysed 47 CSF proteins, suggested to be associated to neurodegeneration, in 66 patients with ALS and explored protein ratios to evaluate their utility in detecting cognitive impairment, hypothesising shared mechanisms between neurodegenerative diseases. Elastic net regression identified the most predictive protein pairs associated with cognitive impairment, assessed with the Edinburgh Cognitive and Behavioural ALS Screen (ECAS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Elastic net identified seven single proteins (NEFM, NPTX2, GAP43, IGFBP4, IGFBP7, SPP1, CDH8) and eight protein pairs associated with ECAS total score. Ratios were generally more informative than individual proteins, with PTPRN2\/GAP43 showing the strongest association with ECAS scores, indicating an enhanced ability to capture cognitive changes. Several of the proteins in the most predictive pairs have previously been implicated to associate to cognitive impairment in AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings indicate that protein ratios outperform single-protein analyses in detecting associations with cognitive impairment, aligning with advancements in AD research. By extending the concept of CSF protein ratios from AD to ALS, this study highlights shared pathological mechanisms and suggests that similar proteins are linked to cognitive dysfunction in both diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-026-01976-y","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T23:26:06Z","timestamp":1769815566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ratios of CSF proteins reflect cognitive function in ALS"],"prefix":"10.1186","volume":"18","author":[{"given":"Linn","family":"\u00d6ijerstedt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1ra","family":"Mravinacov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Olofsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solmaz","family":"Yazdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"De Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inci S.","family":"Aksoylu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Foucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Juto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Kl\u00e4ppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"M\u00e5nberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ingre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"issue":"3\u20134","key":"1976_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","volume":"18","author":"MJ Strong","year":"2017","unstructured":"Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(3\u20134):153\u201374. https:\/\/doi.org\/10.1080\/21678421.2016.1267768.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"7","key":"1976_CR2","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1212\/01.WNL.0000156519.41681.27","volume":"64","author":"S Abrahams","year":"2005","unstructured":"Abrahams S, Leigh PN, Goldstein LH. Cognitive change in ALS: A prospective study. Neurology. 2005;64(7):1222\u20136. https:\/\/doi.org\/10.1212\/01.WNL.0000156519.41681.27.","journal-title":"Neurology"},{"key":"1976_CR3","doi-asserted-by":"publisher","unstructured":"Mravinacov\u00e1 S, Alanko V, Bergstr\u00f6m S, Bridel C, Pijnenburg Y, Hagman G, et al. CSF protein ratios with enhanced potential to reflect alzheimer\u2019s disease pathology and neurodegeneration. Mol Neurodegener. 2024;19(1). https:\/\/doi.org\/10.1186\/s13024-024-00705-z.","DOI":"10.1186\/s13024-024-00705-z"},{"key":"1976_CR4","doi-asserted-by":"publisher","unstructured":"Karlsson L, Vogel J, Arvidsson I, \u00c5str\u00f6m K, Janelidze S, Blennow K, et al. Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseases. Nat Commun. 2024;15(1). https:\/\/doi.org\/10.1038\/s41467-024-47971-5.","DOI":"10.1038\/s41467-024-47971-5"},{"issue":"8","key":"1976_CR5","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1007\/s00415-024-12479-x","volume":"271","author":"L \u00d6ijerstedt","year":"2024","unstructured":"\u00d6ijerstedt L, Foucher J, Lovik A, Yazdani S, Juto A, Kl\u00e4ppe U, et al. Repeated cognitive assessments show stable function over time in patients with ALS. J Neurol. 2024;271(8):5267\u201374. https:\/\/doi.org\/10.1007\/s00415-024-12479-x.","journal-title":"J Neurol"},{"issue":"1","key":"1976_CR6","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41598-024-83281-y","volume":"15","author":"S Mravinacov\u00e1","year":"2025","unstructured":"Mravinacov\u00e1 S, Bergstr\u00f6m S, Olofsson J, de San Jos\u00e9 NG, Anderl-Straub S, Diehl-Schmid J, et al. Addressing inter individual variability in CSF levels of brain derived proteins across neurodegenerative diseases. Sci Rep. 2025;15(1):668. https:\/\/doi.org\/10.1038\/s41598-024-83281-y.","journal-title":"Sci Rep"},{"key":"1976_CR7","doi-asserted-by":"publisher","unstructured":"Oh HS-H, Urey DY, Karlsson L, Zhu Z, Shen Y, Farinas A, et al. A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in alzheimer\u2019s disease. Nat Med. 2025;31(5). https:\/\/doi.org\/10.1038\/S41591-025-03565-2.","DOI":"10.1038\/S41591-025-03565-2"},{"issue":"2","key":"1976_CR8","doi-asserted-by":"publisher","first-page":"e14600","DOI":"10.1002\/alz.14600","volume":"21","author":"L Karlsson","year":"2025","unstructured":"Karlsson L, Vogel J, Arvidsson I, \u00c5str\u00f6m K, Strandberg O, Seidlitz J, et al. Machine learning prediction of tau-PET in alzheimer\u2019s disease using plasma, MRI, and clinical data. Alzheimers Dement. 2025;21(2):e14600. https:\/\/doi.org\/10.1002\/alz.14600.","journal-title":"Alzheimers Dement"},{"issue":"1\u20132","key":"1976_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/21678421.2023.2263874","volume":"25","author":"U Kl\u00e4ppe","year":"2024","unstructured":"Kl\u00e4ppe U, Sennf\u00e4lt S, Lovik A, Finn A, Bofaisal U, Zetterberg H, et al. Neurodegenerative biomarkers outperform neuroinflammatory biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2024;25(1\u20132):150\u201361. https:\/\/doi.org\/10.1080\/21678421.2023.2263874.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"1\u20132","key":"1976_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/21678421.2024.2428930","volume":"26","author":"J Olofsson","year":"2025","unstructured":"Olofsson J, Bergstr\u00f6m S, Mravinacov\u00e1 S, Kl\u00e4ppe U, \u00d6ijerstedt L, Zetterberg H, et al. Cerebrospinal fluid levels of NfM in relation to NfL and pNfH as prognostic markers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2025;26(1\u20132):113\u201323. https:\/\/doi.org\/10.1080\/21678421.2024.2428930.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"8","key":"1976_CR11","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.1007\/S00415-024-12496-W","volume":"271","author":"C Chourpiliadis","year":"2024","unstructured":"Chourpiliadis C, Seitz C, Lovik A, Joyce EE, Pan L, Hu Y, et al. Lifestyle and medical conditions in relation to ALS risk and progression-an introduction to the Swedish ALSrisc study. J Neurol. 2024;271(8):5447\u201359. https:\/\/doi.org\/10.1007\/S00415-024-12496-W.","journal-title":"J Neurol"},{"issue":"1\u20132","key":"1976_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","volume":"169","author":"JM Cedarbaum","year":"1999","unstructured":"Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169(1\u20132):13\u201321. https:\/\/doi.org\/10.1016\/S0022-510X(99)00210-5.","journal-title":"J Neurol Sci"},{"key":"1976_CR13","doi-asserted-by":"publisher","unstructured":"Niven E, Newton J, Foley J, Colville S, Swingler R, Chandran S et al. Validation of the Edinburgh cognitive and behavioural amyotrophic lateral sclerosis screen (ECAS): A cognitive tool for motor disorders. http:\/\/dx.doi.org\/103109\/2167842120151030430.2015;16(3\u20134):172\u20139. https:\/\/doi.org\/10.3109\/21678421.2015.1030430.","DOI":"10.3109\/21678421.2015.1030430"},{"issue":"7\u20138","key":"1976_CR14","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1080\/21678421.2023.2239857","volume":"24","author":"J Foucher","year":"2023","unstructured":"Foucher J, Winroth I, Lovik A, Sennf\u00e4lt S, Pereira JB, Fang F, et al. Validity and reliability measures of the Swedish Karolinska version of the Edinburgh cognitive and behavioral ALS screen (SK-ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2023;24(7\u20138):713\u20138. https:\/\/doi.org\/10.1080\/21678421.2023.2239857.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"7","key":"1976_CR15","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/ACN3.51402","volume":"8","author":"S Bergstr\u00f6m","year":"2021","unstructured":"Bergstr\u00f6m S, Remnest\u00e5l J, Yousef J, Olofsson J, Markaki I, Carvalho S, et al. Multi-cohort profiling reveals elevated CSF levels of brain-enriched proteins in alzheimer\u2019s disease. Ann Clin Transl Neurol. 2021;8(7):1456\u201370. https:\/\/doi.org\/10.1002\/ACN3.51402.","journal-title":"Ann Clin Transl Neurol"},{"key":"1976_CR16","doi-asserted-by":"publisher","unstructured":"Remnest\u00e5l J, Bergstr\u00f6m S, Olofsson J, Sj\u00f6stedt E, Uhl\u00e9n M, Blennow K, et al. Association of CSF proteins with Tau and amyloid \u03b2 levels in asymptomatic 70-year-olds. Alzheimers Res Ther. 2021;13(1). https:\/\/doi.org\/10.1186\/S13195-021-00789-5.","DOI":"10.1186\/S13195-021-00789-5"},{"issue":"1","key":"1976_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12014-024-09517-1","volume":"21","author":"S Bergstr\u00f6m","year":"2024","unstructured":"Bergstr\u00f6m S, Mravinacov\u00e1 S, Lindberg O, Zettergren A, Westman E, Wahlund L-O, et al. CSF levels of brain-derived proteins correlate with brain ventricular volume in cognitively healthy 70-year-olds. Clin Proteom. 2024;21(1):65. https:\/\/doi.org\/10.1186\/s12014-024-09517-1.","journal-title":"Clin Proteom"},{"key":"1976_CR18","doi-asserted-by":"publisher","unstructured":"Remnest\u00e5l J, \u00d6ijerstedt L, Ullgren A, Olofsson J, Bergstr\u00f6m S, Kultima K, et al. Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers. Transl Neurodegener. 2020;9(1). https:\/\/doi.org\/10.1186\/S40035-020-00198-Y.","DOI":"10.1186\/S40035-020-00198-Y"},{"issue":"12","key":"1976_CR19","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/PRCA.201500150","volume":"10","author":"J Remnest\u00e5l","year":"2016","unstructured":"Remnest\u00e5l J, Just D, Mitsios N, Fredolini C, Mulder J, Schwenk JM, et al. CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to alzheimer\u2019s disease. Proteom Clin Appl . 2016;10(12):1242\u201353. https:\/\/doi.org\/10.1002\/PRCA.201500150.","journal-title":"Proteom Clin Appl"},{"key":"1976_CR20","doi-asserted-by":"publisher","unstructured":"Ullgren A, \u00d6ijerstedt L, Olofsson J, Bergstr\u00f6m S, Remnest\u00e5l J, van Swieten JC, et al. Altered plasma protein profiles in genetic FTD \u2013 a GENFI study. Mol Neurodegener. 2023;18(1). https:\/\/doi.org\/10.1186\/s13024-023-00677-6.","DOI":"10.1186\/s13024-023-00677-6"},{"key":"1976_CR21","doi-asserted-by":"publisher","unstructured":"Bergstr\u00f6m S, \u00d6ijerstedt L, Remnest\u00e5l J, Olofsson J, Ullgren A, Seelaar H, et al. A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study. Mol Neurodegener. 2021;16(1). https:\/\/doi.org\/10.1186\/S13024-021-00499-4.","DOI":"10.1186\/S13024-021-00499-4"},{"key":"1976_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/J.CCA.2019.03.243","volume":"494","author":"A Andersson","year":"2019","unstructured":"Andersson A, Remnest\u00e5l J, Nellg\u00e5rd B, Vunk H, Kotol D, Edfors F, et al. Development of parallel reaction monitoring assays for cerebrospinal fluid proteins associated with alzheimer\u2019s disease. Clin Chim Acta. 2019;494:79\u201393. https:\/\/doi.org\/10.1016\/J.CCA.2019.03.243.","journal-title":"Clin Chim Acta"},{"key":"1976_CR23","doi-asserted-by":"publisher","unstructured":"Pin E, Sj\u00f6berg R, Andersson E, Hellstr\u00f6m C, Olofsson J, Jernbom Falk A et al. Array-based profiling of proteins and autoantibody repertoires in CSF. In: Methods in Molecular Biology. Methods Mol Biol; 2019. pp. 303\u201318. https:\/\/doi.org\/10.1007\/978-1-4939-9706-0_19.","DOI":"10.1007\/978-1-4939-9706-0_19"},{"issue":"2","key":"1976_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/J.1467-9868.2005.00503.X","volume":"67","author":"H Zou","year":"2005","unstructured":"Zou H, Hastie T. Regularization and variable selection via the elastic net. J R Stat Soc Ser B Stat Methodol . 2005;67(2):301\u201320. https:\/\/doi.org\/10.1111\/J.1467-9868.2005.00503.X.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"issue":"2","key":"1976_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0022-510X(98)00122-1","volume":"158","author":"M Shoji","year":"1998","unstructured":"Shoji M, Matsubara E, Kanai M, Watanabe M, Nakamura T, Tomidokoro Y, et al. Combination assay of CSF Tau, A\u03b21\u201340 and A\u03b21\u201342(43) as a biochemical marker of alzheimer\u2019s disease. J Neurol Sci. 1998;158(2):134\u201340. https:\/\/doi.org\/10.1016\/S0022-510X(98)00122-1.","journal-title":"J Neurol Sci"},{"issue":"3","key":"1976_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0197-4580(03)00086-1","volume":"25","author":"P Lewczuk","year":"2004","unstructured":"Lewczuk P, Esselmann H, Otto M, Maler JM, Henkel AW, Henkel MK, et al. Neurochemical diagnosis of alzheimer\u2019s dementia by CSF A\u03b242, A\u03b242\/A\u03b240 ratio and total Tau. Neurobiol Aging. 2004;25(3):273\u201381. https:\/\/doi.org\/10.1016\/S0197-4580(03)00086-1.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1976_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13195-019-0485-0","volume":"11","author":"O Hansson","year":"2019","unstructured":"Hansson O, Lehmann S, Otto M, Zetterberg H, Lewczuk P. Advantages and disadvantages of the use of the CSF amyloid \u03b2 (A\u03b2) 42\/40 ratio in the diagnosis of alzheimer\u2019s disease. Alzheimers Res Ther. 2019;11(1):1\u201315. https:\/\/doi.org\/10.1186\/S13195-019-0485-0.","journal-title":"Alzheimers Res Ther"},{"key":"1976_CR28","doi-asserted-by":"publisher","unstructured":"Franzmeier N, Dehsarvi A, Steward A, Biel D, Dewenter A, Roemer SN, et al. Elevated CSF GAP-43 is associated with accelerated Tau accumulation and spread in alzheimer\u2019s disease. Nat Commun. 2024;15(1). https:\/\/doi.org\/10.1038\/S41467-023-44374-W.","DOI":"10.1038\/S41467-023-44374-W"},{"issue":"3","key":"1976_CR29","doi-asserted-by":"publisher","first-page":"E275","DOI":"10.1212\/WNL.0000000000201417","volume":"100","author":"A \u00d6hrfelt","year":"2023","unstructured":"\u00d6hrfelt A, Benedet AL, Ashton NJ, Kvartsberg H, Vandijck M, Weiner MW, et al. Association of CSF GAP-43 with the rate of cognitive decline and progression to dementia in Amyloid-Positive individuals. Neurol . 2023;100(3):E275\u201385. https:\/\/doi.org\/10.1212\/WNL.0000000000201417.","journal-title":"Neurol"},{"key":"1976_CR30","doi-asserted-by":"publisher","unstructured":"Shi D, Ye C, Li A, Sun P, Lan G, Zhang L, et al. Presynaptic loss and axonal degeneration synergistically correlate with longitudinal neurodegeneration and cognitive decline. Alzheimers Dement. 2025;21(6). https:\/\/doi.org\/10.1002\/ALZ.70080.","DOI":"10.1002\/ALZ.70080"},{"issue":"5\u20136","key":"1976_CR31","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/21678421.2023.2192248","volume":"24","author":"J Finsel","year":"2023","unstructured":"Finsel J, Winroth I, Cie\u0107wierska K, Helczyk O, Stenberg EA, H\u00e4ggstr\u00f6m AC, et al. Determining impairment in the Swedish, Polish and German ECAS: the importance of adjusting for age and education. Amyotroph Lateral Scler Frontotemporal Degener. 2023;24(5\u20136):475\u201384. https:\/\/doi.org\/10.1080\/21678421.2023.2192248.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-01976-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-01976-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-01976-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:25:45Z","timestamp":1781630745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-01976-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1976"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-01976-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7913800\/v1","asserted-by":"object"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. An informed consent to participate in research was obtained from each participant. The study was reviewed and approved by the Swedish Ethical Review Authority (diary numbers 2017\/1895-31 and 2018\/1605-31).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}